abs20.txt	purpose		to	investigate	the	implications	of	a	cancer	diagnosis	on	medicationadherence	for	pre-existing	comorbid	conditions		we	explored	statin	adherencepatterns	prior	to	and	following	a	new	diagnosis	of	breast		colorectal		orprostate	cancer	among	a	multi-ethnic	cohort	methods		we	identified	adults	enrolled	at	kaiser	permanente	northern	californiawho	were	prevalent	statin	medication	users		newly	diagnosed	with	breast	colorectal		or	prostate	cancer	between	2000	and	2012		statin	adherence	wasmeasured	using	the	proportion	of	days	covered	(pdc)	during	the	2-year	pre-cancerdiagnosis	and	the	2-year	post-cancer	diagnosis		adherence	patterns	were	assessedusing	generalized	estimating	equations		for	all	cancers	combined	and	stratifiedby	cancer	type	and	race/ethnicity		adjusted	for	demographic		clinical		and	tumorcharacteristics	results		among	10	177	cancer	patients		statin	adherence	decreased	from	pre-	topost-cancer	diagnosis	(adjusted	odds	ratio	(oradj)	0	91		95%	confidence	interval(95%	ci)	0	88-0	94)		statin	adherence	decreased	from	pre-	to	post-cancerdiagnosis	among	breast	(oradj	0	94		95%	ci	0	90-0	99)	and	colorectal	(oradj	0	79	95%	ci	0	74-0	85)	cancer	patients		no	difference	in	adherence	was	observed	amongprostate	cancer	patients	(oradj	1	01		95%	ci	0	97-1	05)		prior	to	cancerdiagnosis		adherence	to	statins	was	generally	higher	among	non-hispanic	whitesand	multi-race	patients	than	other	groups		however		statin	adherence	afterdiagnosis	decreased	only	among	these	two	populations	(oradj	0	85		95%ci	0	85-0	92	and	oradj	0	86		95%	ci	0	76-0	97)		respectively	conclusions		we	found	substantial	variation	in	statin	medication	adherencefollowing	diagnosis	by	cancer	type	and	race/ethnicity	among	a	large	cohort	ofprevalent	statin	users	in	an	integrated	health	care	setting	implications	for	cancer	survivors		improving	our	understanding	of	comorbiditymanagement	and	polypharmacy	across	diverse	cancer	patient	populations	iswarranted	to	develop	tailored	interventions	that	improve	medication	adherence	andreduce	disparities	in	health	outcomes	
